Next-Generation Nutraceutical Gel Systems

Publication ID: 24-11857593_0010_PTD

Published: October 28, 2025

Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Nutraceutical Gel Systems,” Published Technical Disclosure No. 24-11857593_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857593_0010_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,593.

Summary of the Inventive Concept

A paradigm-shifting approach to nutraceutical gel technology, integrating cutting-edge advancements in nanofraction immune modulators, oligomeric proanthocyanidin-rich fruit extracts, and self-healing matrices to revolutionize immune system support and personalized nutrition.

Background and Problem Solved

The original patent for nutraceutical gels, while innovative, has limitations in terms of targeted delivery, personalized nutrition, and adaptability to individual immune profiles. The new inventive concept addresses these limitations by envisioning a next-generation system that leverages liposomal encapsulation, 3D printing, and artificial intelligence to create bespoke nutraceutical gels that adapt to an individual's unique needs.

Detailed Description of the Inventive Concept

The new inventive concept comprises a system of interconnected components, including a gel-based matrix infused with nanofraction immune modulators and OPC-rich fruit extracts, a 3D printing process for precise control over active ingredient distribution, and an artificial intelligence-driven computer system for predicting immune-related disorders and recommending personalized regimens. The system also includes a wearable device for controlled release of nutraceutical gels and a self-healing matrix that repairs itself in response to environmental stressors.

Novelty and Inventive Step

The new claims introduce several novel and non-obvious elements, including the use of liposomal encapsulation for targeted delivery, 3D printing for precise control over active ingredient distribution, and artificial intelligence-driven personalized nutrition. These advancements represent a significant departure from the original patent and demonstrate a new level of sophistication in nutraceutical gel technology.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different types of immune modulators, various matrix materials, and alternative manufacturing processes. Additionally, the system could be adapted for use in different industries, such as veterinary medicine or cosmetics.

Potential Commercial Applications and Market

The next-generation nutraceutical gel system has vast commercial potential in the health and wellness industry, with applications in personalized nutrition, immune system support, and preventative medicine. The system's adaptability and customization capabilities make it an attractive solution for a wide range of consumers, from athletes to seniors.

CPC Classifications

Section	Class	Group
A	A61	A61K36/889
A	A23	A23G4/12
A	A23	A23L29/231
A	A23	A23L29/238
A	A23	A23L29/27
A	A23	A23L29/271
A	A23	A23L29/284
A	A23	A23L33/10
A	A23	A23L33/105
A	A61	A61K36/185
A	A61	A61K36/35
A	A61	A61K36/87
A	A61	A61K47/36
A	A23	A23V2002/00
A	A23	A23V2200/324
A	A23	A23V2250/21
A	A23	A23V2250/21166
A	A23	A23V2250/506
A	A23	A23V2250/5086
A	A23	A23V2250/708
A	A61	A61K2300/00

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Nutraceutical formulation and delivery systems, focusing on gel-based nutritional supplements with immune-modulating compounds, encompassing food science, pharmaceutical technology, and biotechnology

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in food science, biotechnology, or pharmaceutical engineering, possessing expertise in supplement formulation, polymer chemistry, and drug delivery mechanisms, with knowledge of gel matrices, immune modulators, and extraction techniques

Obviousness Rationale

A person skilled in the art would recognize that the PTD's disclosed variations represent predictable extensions of the source patent's core technology, leveraging known techniques in nanofraction encapsulation, 3D printing, and personalized nutrition to enhance the original gel-based nutraceutical delivery system. The fundamental approach of dispersing immune modulators and proanthocyanidins in a gel matrix remains consistent, with the PTD introducing incremental technological improvements that would be obvious to a skilled practitioner.

Obvious Combinations & Variations

Source Patent Element

Gel matrix comprising xanthan and guar gum with transfer factor and oligomeric proanthocyanidin

PTD Variation

Liposomal encapsulation of nanofraction immune modulators within the gel matrix

Obviousness Reasoning

Liposomal delivery is a known technique in pharmaceutical science for improving compound bioavailability, and a PHOSITA would find it an obvious method to enhance the original gel's active ingredient distribution

Source Patent Element

Oligomeric proanthocyanidin-containing fruit extract dispersed in gel

PTD Variation

3D printing process for precise control of active ingredient distribution

Obviousness Reasoning

Advanced manufacturing techniques like 3D printing represent a predictable technological progression for improving precision in supplement formulation, which would be an obvious optimization to a skilled practitioner

Source Patent Element

Nutraceutical gel composition with transfer factor and fruit-derived compounds

PTD Variation

AI-driven personalization system for recommending nutraceutical gel regimens

Obviousness Reasoning

Personalized medicine and data-driven health recommendations are emerging trends that a PHOSITA would recognize as a logical extension of existing nutritional supplement technologies

Source Patent Element

Gel matrix with immune modulating compounds

PTD Variation

Self-healing matrix that repairs itself in response to environmental stressors

Obviousness Reasoning

Smart materials and responsive polymer systems are well-known in materials science, and adapting such technologies to nutraceutical delivery would be an obvious design choice for a skilled researcher

Source Patent Element

Nutraceutical gel with transfer factor and proanthocyanidin

PTD Variation

Wearable device for controlled release of nutraceutical gels with integrated immune response monitoring

Obviousness Reasoning

Wearable health technology and controlled-release mechanisms are established fields, and combining them with nutraceutical delivery represents a predictable technological integration

35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857593 and the published technical disclosure, a person having ordinary skill in the art would find the claimed variations obvious, as they represent predictable technological extensions employing known techniques in nanofraction encapsulation, personalized nutrition, and advanced manufacturing processes. The disclosed innovations constitute prima facie obviousness under 35 U.S.C. § 103, rendering subsequent claims involving similar technological approaches anticipated and unpatentable.

Original Patent Information

Patent Number	US 11,857,593
Title	Nutraceutical gels
Assignee(s)	4Life Patents, LLC